TCRGP

TCRGP predicts T cell receptor (TCR) recognition of specific epitopes using a Gaussian process framework to model sequence-based TCR specificity.


Key Features:

  • Gaussian Process Methodology: Employs a Gaussian process framework to model complex relationships in TCR sequence data for epitope recognition prediction.
  • Utilization of CDR Sequences: Analyzes amino acid sequences from complementarity determining regions (CDRs) of both TCRα and TCRβ chains and identifies which CDRs are essential for epitope recognition.
  • Single-Cell Data Integration: Processes single-cell data, including combined scRNA and TCRαβ sequencing datasets.
  • High Prediction Accuracy: Demonstrates superior prediction performance on epitope-specific TCR sequencing data as quantified by higher average AUROC scores compared to existing methods.

Scientific Applications:

  • Understanding Immune Status: Assesses TCR specificity to inform individuals' immune status across various disorders.
  • Epitope-Specific Analysis: Predicts which CDRs are crucial for recognizing specific epitopes to elucidate TCR–epitope interactions.
  • Single-Cell RNA and TCR Sequencing Integration: Quantifies epitope-specific TCRs and identifies epitope-specific immune cells (e.g., HBV-epitope specific T cells) and their transcriptomic states in contexts such as hepatocellular carcinoma.

Methodology:

Applies a Gaussian process model to amino acid sequences from CDRs of TCRα and TCRβ, processes single-cell scRNA and TCRαβ sequencing data, and is evaluated on epitope-specific TCR sequencing datasets using AUROC metrics.

Topics

Details

License:
MIT
Tool Type:
command-line tool
Programming Languages:
R
Added:
12/13/2021
Last Updated:
12/13/2021

Operations

Publications

Jokinen E, Huuhtanen J, Mustjoki S, Heinonen M, Lähdesmäki H. Predicting recognition between T cell receptors and epitopes with TCRGP. PLOS Computational Biology. 2021;17(3):e1008814. doi:10.1371/journal.pcbi.1008814. PMID:33764977. PMCID:PMC8023491.

PMID: 33764977
PMCID: PMC8023491
Funding: - Academy of Finland: 311584 (Quantifying molecular networks at single-cell level), 313271 (ICT 2023 programme: TensorMed consortium), 314442 (Terva Program: Heal-Art consortium), 314445 (Terva program: Heal-Art consortium), 335436 (Terva program: Heal-Art consortium) - H2020 European Research Council: 647355 (M-IMM project) - ERA PerMed: (JAKSTAT-TARGET consortium)

Links